Kisspeptin-10 reconstitution calculator
- Concentration
- 2.5 mg/mL
- Doses per vial
- 20
- Weeks (1 dose/wk)
- 20
10 units (0.1 mL) on a 1 mL U-100 syringe: 250 mcg from a 5 mg vial + 2 mL water (Kisspeptin-10).
Dosing table for a 5 mg vial
Syringe units (U-100) for each dose, by how much bacteriostatic water you add.
| Dose | 1 mL water | 2 mL water | 2.5 mL water | 3 mL water |
|---|---|---|---|---|
| 100 mcg | 2 | 4 | 5 | 6 |
| 250 mcg | 5 | 10 | 12.5 | 15 |
| 500 mcg | 10 | 20 | 25 | 30 |
| 750 mcg | 15 | 30 | 37.5 | 45 |
| 1000 mcg | 20 | 40 | 50 | 60 |
How the math works
Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.
250 mcg = 0.25 mg; 0.25 mg ÷ 2.5 mg/mL = 0.1 mL
0.1 mL × 100 = 10 units
How many units is 250 mcg of Kisspeptin-10?
With a 5 mg vial and 2 mL of bacteriostatic water, 250 mcg is 10 units (0.10 mL) on a U-100 syringe. With 1 mL of water it is 5 units. The answer always depends on how much water was added.
How much bacteriostatic water for a 5 mg Kisspeptin-10 vial?
The water only sets the concentration; the amount of Kisspeptin-10 in the vial stays the same. 2 mL makes 2.5 mg/mL, so 250 mcg is 10 units. 2.5 mL makes 2 mg/mL, so the same 250 mcg is 12.5 units. More water makes small doses easier to measure but needs more volume per injection.
How many 250 mcg doses are in a 5 mg vial?
5 mg is 5,000 mcg; 5,000 ÷ 250 = 20, so 20 full doses of 250 mcg. Any liquid lost in the needle and vial is not counted.
How to reconstitute kisspeptin?
No label exists. The generic arithmetic gives 5 mg/mL for a 5 mg vial in 1 mL, 2.5 mg/mL in 2 mL and 1 mg/mL in 5 mL.
Calculated from vial mg 5; water m L 1, 2, 5. Formula: 5/1 = 5; 5/2 = 2.5; 5/5 = 1 mg/mL
Is there a kisspeptin dosage calculator figure in the trials?
Not in a mcg-per-injection form for kisspeptin-10: the trials use μg/kg boluses, nmol/kg/h infusions, or nmol/kg subcutaneous injections of kisspeptin-54.[4]
Preset doses are round numbers for the arithmetic, not dosing guidance. Vial sizes are the ones most often mentioned for Kisspeptin-10 in community discussions.
The calculator is for kisspeptin-10; one cited trial used kisspeptin-54
One trial of repeated injections in women with hypothalamic amenorrhea used kisspeptin-54, a longer form: twice-daily subcutaneous injections of 6.4 nmol/kg for 2 weeks.[3]
A dose-response study of the 10-amino-acid form, kisspeptin-10, gave intravenous bolus doses from 0.01 to 3.0 μg/kg to healthy men, with the maximal LH rise at 1 μg/kg.[4]
A kisspeptin-10 study gave subcutaneous infusions of 1.25-10.0 nmol/kg/h over 8 h, then daily 8 h infusions at 150 nmol/h for 12 days.[5]
A synthetic receptor agonist, MVT-602, was tested as single subcutaneous doses of 0.1 to 3.0 μg; it is a different compound from kisspeptin.[6]
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis.The Journal of clinical endocrinology and metabolism · 2009PMID 19820030Accessed 2 Oct 2026
- 4Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men.The Journal of clinical endocrinology and metabolism · 2011PMID 21632807Accessed 2 Oct 2026
- 5Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men.European journal of endocrinology · 2026PMID 42549827Accessed 2 Oct 2026
- 6Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals.Fertility and sterility · 2024PMID 37925096Accessed 2 Oct 2026
Found an error? Report a correction.